Re-treatment of relapsed indolent B-cell lymphoma with rituximab.
Igarashi T, Ohtsu T, Fujii H, Sasaki Y, Morishima Y, Ogura M, Kagami Y, Kinoshita T, Kasai M, Kiyama Y, Kobayashi Y, Tobinai K; IDEC-C2B8 Study Group.
Igarashi T, et al. Among authors: ogura m.
Int J Hematol. 2001 Feb;73(2):213-21. doi: 10.1007/BF02981940.
Int J Hematol. 2001.
PMID: 11372734
Clinical Trial.